Ashfield Capital Partners’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $32.8M | Sell |
64,877
-478
| -0.7% | -$251K | 2.75% | 4 |
|
|
2022
Q2 | $33.6M | Sell |
65,355
-608
| -0.9% | -$305K | 2.61% | 5 |
|
|
2022
Q1 | $33.6M | Sell |
65,963
-763
| -1% | -$368K | 2.18% | 7 |
|
|
2021
Q4 | $33.5M | Sell |
66,726
-1,366
| -2% | -$618K | 2.15% | 7 |
|
|
2021
Q3 | $26.6M | Buy |
68,092
+209
| +0.3% | +$86.6K | 1.89% | 10 |
|
|
2021
Q2 | $27.2M | Sell |
67,883
-184
| -0.3% | -$73.4K | 1.94% | 8 |
|
|
2021
Q1 | $25.3M | Sell |
68,067
-179
| -0.3% | -$62K | 2.01% | 8 |
|
|
2020
Q4 | $23.9M | Buy |
68,246
+405
| +0.6% | +$136K | 1.94% | 8 |
|
|
2020
Q3 | $21.2M | Sell |
67,841
-491
| -0.7% | -$151K | 1.92% | 10 |
|
|
2020
Q2 | $20.2M | Sell |
68,332
-1,219
| -2% | -$349K | 1.99% | 10 |
|
|
2020
Q1 | $17.3M | Buy |
69,551
+6,395
| +10% | +$1.76M | 2.11% | 6 |
|
|
2019
Q4 | $18.6M | Sell |
63,156
-57
| -0.1% | -$14.9K | 1.85% | 9 |
|
|
2019
Q3 | $13.7M | Sell |
63,213
-779
| -1% | -$188K | 1.49% | 18 |
|
|
2019
Q2 | $15.6M | Buy |
63,992
+31
| +0% | +$7.46K | 1.67% | 12 |
|
|
2019
Q1 | $15.8M | Buy |
63,961
+1,461
| +2% | +$373K | 1.74% | 10 |
|
|
2018
Q4 | $15.6M | Buy |
62,500
+790
| +1% | +$209K | 2.03% | 8 |
|
|
2018
Q3 | $16.4M | Buy |
61,710
+12,782
| +26% | +$3.32M | 1.84% | 7 |
|
|
2018
Q2 | $12M | Buy |
48,928
+237
| +0.5% | +$56.9K | 1.5% | 15 |
|
|
2018
Q1 | $10.4M | Buy |
48,691
+1,042
| +2% | +$238K | 1.36% | 17 |
|
|
2017
Q4 | $10.5M | Sell |
47,649
-201
| -0.4% | -$42.6K | 1.35% | 16 |
|
|
2017
Q3 | $9.37M | Buy |
47,850
+447
| +0.9% | +$86.4K | 1.26% | 23 |
|
|
2017
Q2 | $8.79M | Sell |
47,403
-1,355
| -3% | -$238K | 1.2% | 23 |
|
|
2017
Q1 | $8M | Sell |
48,758
-2,780
| -5% | -$455K | 1.11% | 25 |
|
|
2016
Q4 | $8.25M | Sell |
51,538
-852
| -2% | -$127K | 0.81% | 45 |
|
|
2016
Q3 | $7.33M | Buy |
52,390
+11,524
| +28% | +$1.61M | 0.6% | 56 |
|
|
2016
Q2 | $5.77M | Hold |
40,866
| – | – | 0.46% | 63 |
|
|
2016
Q1 | $5.27M | Sell |
40,866
-589
| -1% | -$69.7K | 0.38% | 71 |
|
|
2015
Q4 | $4.88M | Sell |
41,455
-1,807
| -4% | -$211K | 0.33% | 73 |
|
|
2015
Q3 | $5.02M | Sell |
43,262
-219
| -0.5% | -$26.2K | 0.32% | 69 |
|
|
2015
Q2 | $5.3M | Buy |
43,481
+605
| +1% | +$71.6K | 0.29% | 71 |
|
|
2015
Q1 | $5.07M | Sell |
42,876
-534
| -1% | -$59.3K | 0.27% | 71 |
|
|
2014
Q4 | $4.39M | Buy |
43,410
+114
| +0.3% | +$10.8K | 0.21% | 79 |
|
|
2014
Q3 | $3.73M | Buy |
43,296
+1,066
| +3% | +$90.1K | 0.18% | 85 |
|
|
2014
Q2 | $3.45M | Sell |
42,230
-315
| -0.7% | -$24.8K | 0.16% | 94 |
|
|
2014
Q1 | $3.49M | Buy |
42,545
+127
| +0.3% | +$9.56K | 0.17% | 90 |
|
|
2013
Q4 | $3.19M | Sell |
42,418
-573
| -1% | -$41.2K | 0.15% | 92 |
|
|
2013
Q3 | $3.08M | Sell |
42,991
-89
| -0.2% | -$6.37K | 0.16% | 93 |
|
|
2013
Q2 | $2.82M | Buy |
+43,080
| New | +$2.68M | 0.15% | 96 |
|
Other funds holding UNH
Ashfield Capital Partners's UNH Position: Q3 2022 in Review
Ashfield Capital Partners reduced its UnitedHealth (UNH) stake by 0.73% in Q3 2022, selling an estimated $251K and leaving 64,877 shares worth $32.8M. The position accounts for 2.75% of the portfolio, ranked #4.
Ashfield Capital Partners first reported a position in UNH in Q2 2013 and has held it in 38 quarters since. The position peaked at $33.6M in Q1 2022. 2,993 funds tracked by Wall St. Rank hold UNH as of Q3 2022.
- Ashfield Capital Partners held 64,877 shares of UnitedHealth worth $32.8M as of Q3 2022.
- Ashfield Capital Partners sold 478 UnitedHealth shares in Q3 2022, an estimated $251K.
- UnitedHealth made up 2.75% of Ashfield Capital Partners's portfolio in Q3 2022, its #4 holding.
- Ashfield Capital Partners first reported a position in UnitedHealth in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's UnitedHealth position peaked at $33.6M in Q1 2022.
- 2,993 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.